These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9510934)
1. Serological testing during pregnancy in women given routine antenatal anti-D Ig prophylaxis. de Silva PM; Knight RC Transfus Med; 1997 Dec; 7(4):323-4. PubMed ID: 9510934 [No Abstract] [Full Text] [Related]
2. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women. Kornstad L NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469 [TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis with anti D immunoglobulins in Rh negative women. Gupta I; Jolly JG; Gupta AN Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352 [No Abstract] [Full Text] [Related]
4. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization]. Högman C; Nilsson BA Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372 [No Abstract] [Full Text] [Related]
5. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Kumpel BM Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599 [No Abstract] [Full Text] [Related]
6. Elevated anti-D titer after the administration of Rh immune globulin. A case report. Andres RL; Branch DW; Scott JR J Reprod Med; 1989 Apr; 34(4):318-20. PubMed ID: 2497253 [TBL] [Abstract][Full Text] [Related]
7. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant. Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601 [No Abstract] [Full Text] [Related]
9. [Prenatal diagnosis and current status of the prevention of feto-maternal isoimmunization by anti-D]. Martín Vega C Sangre (Barc); 1997 Jun; 42(3):239-41. PubMed ID: 9381270 [No Abstract] [Full Text] [Related]
10. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative. Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602 [TBL] [Abstract][Full Text] [Related]
11. Economics of anti-rhesus prophylaxis in an African population. Verkuyl DA Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186 [No Abstract] [Full Text] [Related]
12. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study. Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487 [TBL] [Abstract][Full Text] [Related]
17. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants. Boulet S; Krause C; Tixier H; Bardou M; Sagot P Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403 [TBL] [Abstract][Full Text] [Related]
18. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy]. Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477 [TBL] [Abstract][Full Text] [Related]
19. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis. Tuohy JF; Sangalli M; Kim L Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870 [TBL] [Abstract][Full Text] [Related]
20. [Immunohematological surveillance of the pregnant woman: new prevention policy]. Mannessier L Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]